Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
16.11
+0.43 (2.74%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
According to 25 analysts polled by S&P Global, Tandem Diabetes Care stock has a consensus rating of "Buy" and an average price target of $27.86. The average 1-year stock price forecast is 72.94% higher than the current stock price, while the lowest is $18 (+11.73%) and the highest is $50 (+210.37%).
Price Target: $27.86 (+72.94%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 11 | 11 | 11 |
| Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Hold | 11 | 10 | 11 | 11 | 10 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 24 | 24 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $18 | Hold | Maintains | $18 | +11.73% | Oct 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $26 | Buy | Maintains | $26 | +61.39% | Oct 1, 2026 |
| Citi | Citi | Hold Maintains $24 → $20 | Hold | Maintains | $24 → $20 | +24.15% | Sep 30, 2026 |
| Lake Street | Lake Street | Buy Reiterates $50 | Buy | Reiterates | $50 | +210.37% | Sep 28, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $31 → $28 | Buy | Reiterates | $31 → $28 | +73.81% | Sep 24, 2026 |
Financial Forecast
Revenue This Year
1.07B
from 1.01B
Increased by 5.69%
Revenue Next Year
1.20B
from 1.07B
Increased by 12.35%
EPS This Year
-0.66
from -2.58
EPS Next Year
0.16
from -0.66
EPS and Forward PE are based on non-GAAP adjusted numbers.